Áttétes emlőrák: vizsgálatok itt: Belgium
34 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in BelgiumAntibody-based PET Imaging and Treatment Response in Breast Cancer Treated With an Antibody-drug Conjugate.
- Where
- Anderlecht
- Életkor
- 18 év and over
- People
- 30
- Run by
- UNICANCER
See details and how to joinNCT07294430 · EU 2025-524369-26-00 - 2. fázisTaking peopleSafety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
- Where
- Brasschaat, Gent, Mons, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- MedSIR
See details and how to joinNCT06486883 · EU 2024-512360-55-00 - 1/2. fázisTaking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Anderlecht, Leuven
- Életkor
- 18 év and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - 1. fázisTaking peopleFirst-in-Human Study of OKI-219 Alone and in Combination with Other Therapies in Patients with Solid Tumors / Breast Cancer
- Where
- Anderlecht, Antwerp, Edegem, Leuven
- Életkor
- 18 év and over
- People
- 145 worldwide
- Run by
- Onkure Inc.
See details and how to join2023-508435-31-00 - 3. fázisFut, nem toborozTrastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
- Where
- Antwerp, Brussels, Jette, Leuven, Liège, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT05950945 · EU 2023-505616-38-00 - 1/2. fázisTaking peopleBeamion BCGC-1: A study to find a suitable dose of zongertinib used alone and in combination with other treatments to test whether it helps people with different types of HER2+ cancer that has spread
- Where
- Edegem, Leuven, Libramont-Chevigny, Namur, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 181 worldwide
- Run by
- Boehringer Ingelheim International GmbH
See details and how to join2023-509566-38-00 - 1. fázisTaking peoplePhase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
- Where
- Anderlecht
- Életkor
- 18 év and over
- People
- 76 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2023-510356-23-00 - 2. fázisTaking peopleBicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
- Where
- Antwerp, Edegem, Gent, Hasselt, Jette, Leuven
- Életkor
- 18 év and over
- People
- 53
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT06365788 · EU 2022-502272-23-00 - No phaseTaking peopleStereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)
- Where
- Brussels, Ghent, Kortrijk, Mechelen, Namur
- Életkor
- 18 év and over
- People
- 48
- Run by
- Jules Bordet Institute
See details and how to joinNCT06925984